OSI Systems Announces Launch of the MCare 300 Low Acuity Patient Monitor
The MCare 300 is a stand alone low acuity patient monitor as compared to the Companys successful UltraviewSL patient monitor product line which is fully networked within the hospitals IT infrastructure. The MCare 300 can be customized to meet the customers specifications for patient parameters to be monitored. Standard configuration includes 3 and 5 lead electrocardiogram (ECG), respiration, SPO2, temperature and non-invasive blood pressure monitoring. The monitor utilizes the same touch screen interface as the UltraviewSL product line and is equipped with internal default alarms that can be configured for adult, pediatric and neonatal patients.
The product is ideally suited for day surgery centers and also traditional hospitals where it could be used as a step down unit bridging the gap between their high-end networked monitoring systems and stand alone monitoring. The monitor will be available in nineteen languages and distributed internationally through the Companys distributors and direct sales force. Distribution within the U.S. follows receipt earlier of 510(k) approval from the U.S. Food and Drug Administration (FDA) permitting the MCare 300 to be distributed in the United States market.
Deepak Chopra, OSI Systems CEO, stated, The launch of the new MCare 300 low acuity patient monitor is an important step in growing our patient monitoring business internationally, especially in the emerging markets of India and China. The product was designed and developed to specifically address the opportunity in the growing day surgery center market while also enabling us to provide a stand alone patient monitor to our traditional customer base. While the day surgery center market is a new market for us, we intend to utilize our strong global brand recognition and extensive international distribution channels to make the launch a success.
About OSI Systems, Inc.
OSI Systems, Inc. is a Hawthorne, California based vertically-integrated provider of specialized electronic products for critical applications in the Security and Healthcare industries. The company has more than 30 years of experience in electronics engineering and manufacturing and maintains offices and production facilities located in more than a dozen countries. OSI Systems implements a strategy of expansion by leveraging its electronics and contract manufacturing capabilities into selective end product markets through organic growth and acquisitions. For more information on OSI Systems Inc. or any of its subsidiary companies, visit www.osi-systems.com.
About Spacelabs Healthcare, Inc.
Spacelabs Healthcare, Inc. (www.spacelabshealthcare.com) is an international developer, manufacturer and distributor of medical equipment and services including patient monitoring solutions, anesthesia delivery and ventilation systems, diagnostic cardiology solutions and supplies and accessories selling to hospitals, clinics and physicians offices. Additionally, the company provides ECG laboratory services to pharmaceutical companies undertaking clinical trials, whereby patient ECG data is recorded, analyzed, tabulated and interpreted.
The company has established brand names in both medical devices and medical services such as "Spacelabs," "Blease," Del Mar Reynolds and "Dolphin." It employs approximately 1,500 personnel in its offices located in the United States, UK, Canada, France, Germany, Finland, India and Singapore.
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such statements include information regarding the Companys expectations, goals or intentions about the future, including, but not limited to, statements regarding the launch of the MCare 300, locations where it will be used by customers, languages in which it will operate, and the resources that the Company will utiliz in the launch of this product. The actual results may differ materially from those described in or implied by any forward-looking statement. Other important factors are set forth in the Securities and Exchange Commission filings of OSI Systems, Inc. All forward-looking statements speak only as of the date made, and we undertake no obligation to update these forward-looking statements.
For Further Information
OSI Systems, Inc.
12525 Chadron Ave
Hawthorne CA 90250
(310) 349 2237
Contact: Jeremy Norton Director of Investor Relations